Global duck meat market to accelerate growth over the next 4 years
The duck meat market is set for growth in the following years, according to the latest global market report from Technavio covering the period between 2021-2025. A CAGR of 3% in the global market is expected over the next 4 years, with the APAC region acting as the main driver for this expansion.
"APAC will provide maximum growth opportunities in the duck meat market during the forecast period. According to our research report, the region will contribute to 74% of the global market growth and is expected to dominate the market through 2025. China, Japan, and Malaysia are the key countries for the duck meat market in APAC. Market growth in this region will be faster than the growth of the market in MEA. The increasing health awareness, the convenience offered by processed meats, and the expanding fast-food chains will drive the duck meat market growth in APAC during the forecast period," analysts forecast.
Also, the duck meat market share growth by the fresh duck meat segment will be significant during the forecast period. The increasing availability of fresh duck meat through supermarkets, hypermarkets, convenience stores, and other distribution channels will drive the growth of the fresh duck meat market during the forecast period. The high demand for protein-rich food products and increased disposable income levels are also driving the segment.
Currently, the global duck meat market is primarily driven by the rising awareness about the health benefits associated with the consumption of duck meat. This is leading to an increase in demand for fresh duck meat as well as processed duck meat. Hence, several major vendors are expanding their production capacities to meet the growing demand. This has led to the availability of a wide range of product choices in the market.
The Taskforce will guide the domestic livestock transport industry's focus on three pillars: anim...
Senasa reported that, in addition to ongoing contact with Mexican authorities and private sector ...
GenMar Pharma GmbH, based in Oberhaching near Munich, is building a state-of-the-art biotechnolog...
